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Background: Neurological abnormalities are a key factor in the prognosis of patients with post-cardiac arrest
syndrome. In this study, we evaluated whether differences in CT measurements expressed in Hounsfield units (HUs)
of the cerebral cortex and white matter can be used as early predictors of neurological outcome in patients treated
with hypothermia therapy after hypoxic-ischemic brain damage.
Methods: We performed a retrospective study of 58 patients resuscitated after cardiac arrest between 2007 and
2010 who were treated with hypothermia therapy for the initial 24 hours post resuscitation. We divided the
patients into 4 groups according to Glasgow Outcome Scale (GOS) score (GOS 1, GOS 2, GOS 3&4, and GOS 5) and
assessed the correlations between GOS scores and HU differences between the cerebral cortex and white matter (DCW).
Results: The HU values of the cerebral cortex gradually decreased in accordance with worsening of neurological
outcome. There were no significant intergroup differences in the HUs of the white matter among the groups. The
DCW values were higher in patients with good neurological outcomes. The cut-off value for DCW indicative of poor
neurological outcome was less than 5.5 in the GOS 1&2 groups, with a sensitivity of 63% and a specificity of 100%.
Conclusions: This study showed that DCW values may be used for the prediction of neurological outcome of patients
with post-cardiac arrest syndrome in the very early phase following the return of spontaneous circulation. Especially, a
cut-off value for DCW of less than 5.5 may indicate poor neurological outcome.
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Post-cardiac arrest syndrome consists of several symp-
toms that resuscitated patients exhibit after cardiac arrest,
such as neurological dysfunction, cardiac failure, and re-
spiratory distress [1]. Of these symptoms, neurological
dysfunction is a key factor for determining the prognosis
of patients post cardiac arrest. Hypothermia is a helpful
therapeutic approach for the protection of brain cells in
patients who remain comatose after the return of spontan-
eous circulation (ROSC). Preclinical and clinical evidence
strongly supports therapeutic hypothermia as an effective
therapy for post-cardiac arrest syndrome [1].* Correspondence: yamamura@med.osaka-cu.ac.jp
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distribution, and reproduction in any mediumHead computed tomography (CT) is often performed
early following ROSC to evaluate brain hemorrhage or
infarction in post-cardiac arrest patients. From our ex-
perience with head CT findings in such patients, we
found that patients with hypoxic-ischemic brain damage
following cardiac arrest showed a loss of difference be-
tween gray matter (GM) and white matter (WM), diffuse
brain swelling, and decreased basal ganglia density [2,3].
Several studies have examined the correlations between
CT findings and the prognosis of patients with post-
cardiac arrest syndrome. Torbey et al. demonstrated a
correlation between GM/WM ratios measured at the
level of the basal ganglia and neurological outcomes in
patients after ROSC [4]. A loss of GM/WM differenti-
ation on CT has been reported to predict poor outcometral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Measurement points of head computed tomography
at the basal ganglial level. The indicated points were measured in
Hounsfield units. Open circles indicate the positioning of the 10-mm2
regions of interest in the cerebral cortex. Open triangles indicate the
positioning of the regions of interest in the white matter 1. Square
symbols indicate the hallmarks placed to divide the distance from the
frontal pole to occipital pole into four equal parts.
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However, no studies have evaluated CT scans that were
performed within a few hours of ROSC and the outcome
of patients after ROSC.
This study aimed to evaluate whether differences in
CT measurements expressed in Hounsfield units (HUs)
of the cerebral cortex and WM can be used as early pre-
dictors of neurological outcome in patients undergoing
therapeutic hypothermia after hypoxic-ischemic brain
damage.
Methods
Of 310 adult patients who had been resuscitated after
cardiac arrest in our center between October 2007 and
January 2010, we retrospectively evaluated 58 patients
who had undergone head CT within 2 hours of ROSC
and survived 24 hours after ROSC and who did not meet
the following exclusion criteria: 1) intracranial hemor-
rhage or brain infarction as a cause of cardiac arrest, and
2) death within 48 hours from respiratory or heart fail-
ure. Spontaneous circulation did not return in 183 of the
310 patients resuscitated. The remaining 69 patients
were excluded for the following reasons: intracranial
hemorrhage or brain infarction (n = 29); lack of CT data
(n = 18); and death within 48 hours, which included pa-
tients whose families did not desire hypothermia treat-
ment (n = 22).
The patients in this study were treated with constant
hypothermia therapy for its curative effect. They were
cooled to a temperature range of 33°C to 35°C for the
initial 24 hours after ROSC with external cooling de-
vices, which included water-circulating cooling blankets
(Medi-Therm® III; Gaymar Industries, Inc., New York,
NY, USA) or the Arctic Sun® 5000 system (Medivance,
Inc., Louisville, CO, USA). All patients were given seda-
tives and neuromuscular blockade to prevent shivering.
All data pertaining to clinical presentation, including
age, sex, cause of death, witnessed collapse, bystander
cardiopulmonary resuscitation, resuscitation time, time
between initial CT scan and ROSC, and Glasgow Out-
come Scale (GOS) scores, were collected from patient
medical records. Neurological outcome of the patients
was assessed with the GOS score at the time of dis-
charge from hospital.
We divided the patients into 4 groups according to
GOS score: 1 (GOS 1 group, n = 24), 2 (GOS 2 group,
n = 18), 3 and 4 (GOS 3&4 group, n = 6), and 5 (GOS
5 group, n = 10). The head CT scans of 20 pre-
cardiovascular surgery patients, which were interpreted by
radiologists to be within normal range, were used as the
control group.
CT scan images were obtained on an Aquilion™ CT
system (Toshiba, Tokyo, Japan). All CT images were
non-contrast-enhanced 5-mm axial sections obtainedparallel to the orbitomeatal baseline at 135 kV and
150 mA. Images were viewed on a 512 × 512-pixel moni-
tor on an electrical communication system. We obtained
the HU measurements of the cerebral cortex and WM1
at 6 points (bilateral frontal, temporal, and occipital
lobes). A radiologist standardized the placement of mea-
surements at the basal ganglia level. We drew a center
line from the frontal pole to the occipital pole and
placed hallmarks at the quarter, halfway, and three-
quarter points to divide the length into 4 equal parts.
We then drew lines perpendicular to the center line to
the right and left of these three hallmarks and placed
ROIs (10 mm2) along these lines at 2 mm inside the cra-
nial bone on either side as measurement points of the
“cerebral cortex” (denoted by circle symbols) and at
15 mm inside of these points as measurement points of
the “WM1” (denoted by triangle symbols) (Figure 1). We
also obtained the HU values of the GM and WM using
the method described by Torbey et al., whereby GM
values were obtained from the caudate nucleus and pu-
tamen and WM2 values were obtained from the poste-
rior limb of the internal capsule and genu of the corpus
callosum at the basal ganglia level on non-contrast CT
scans [4]. We selected these points to avoid beam-
hardening artifacts of bone. The average values of the
cerebral cortex and of the WM1 at the 6 points were
Table 2 Assessment of HU values in regions of interest
and the gray matter/white matter 2 ratio in GOS 1&2
and 3–5 patients
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and WM1 in that area.
The difference in HU values between the cerebral
cortex and WM1 (DCW) was calculated as the differ-
ence between the mean HU value of the cerebral cortex
and mean HU value of the WM1. We also assessed the
correlations between the GOS scores and the DCW.
These assessments were performed after patients were
discharged from hospital, and all CT scans were evalu-
ated independently on an X-ray viewer in the intensive
care unit by an emergency physician who was blinded
to the clinical findings and patient data. The study was
approved by the local ethics committee of our univer-
sity hospital.
Statistical Analysis
Data are expressed as mean ± standard deviation (SD).
Differences in HUs between the cerebral cortex and
WM1 between the controls and the 4 subgroups were
compared with one-way analysis of variance (ANOVA)
and post hoc comparison using Scheffé’s method. Using
the ROC method, we calculated the sensitivity, specifi-
city, and area under the curve (AUC) to determine the
diagnostic accuracy of our findings. P values of less than
0.05 were considered significant.
Results
Patient characteristics are presented in Table 1. There
were significant differences between the 4 GOS groups
with respect to witnessed arrest, time interval between
cardiac arrest and ROSC, and time interval between
ROSC and CT. The mean time intervals between cardiac
arrest and ROSC were shorter in patients with good
neurological outcomes. The mean duration from ROSC
to attainment of the hypothermia target temperatureTable 1 Clinical characteristics of the 4 patient groups
Glasgow outcome scale
1 2 3&4 5 P
No. 24 18 6 10
Male/Female, N 17/7 15/3 5/1 5/5 0.442
Age, years 65 ± 16 66 ± 18 73 ± 15 65 ± 11 0.754
Time between cardiac
arrest and ROSC, min
53 ± 22 38 ± 12 30 ± 4 20 ± 15 <0.0001*
Time between ROSC
and CT, min
35 ± 16 35 ± 11 60 ± 45 65 ± 50 0.012*
Witnessed arrest,% 24 61 83 90 <0.001*
Cause of cardiac arrest
Cardiogenic 2 10 4 8
Asphyxia 14 3 1 0
Others 8 5 1 2
ROSC, return of spontaneous circulation; CT, computed tomography.
* Statistically significant (P < 0.05).(35°C) was 115 + 104 min. The temperature of 16 patients
at ROSC was below 35°C. The number of hospital
days was 21 ± 21 days (range, 3 – 96 days). In the pa-
tients in GOS 1 group who died, duration of survival
was 4.6 ± 2.1 days (range, 3 – 9 days).
The HU densities of the cerebral cortex, caudate nu-
cleus, and posterior limb of the internal corpus callosum,
and the DCW were significantly lower in the GOS 1&2
groups than in the GOS 3–5 groups (Table 2). The GM/
WM2 ratios were not significantly different between these
two composite groups.
The HUs of the cerebral cortex and WM1 are shown in
Figure 2. The HU values of the cerebral cortex gradually
decreased in accordance with worsening of neurological
outcome. There were no significant intergroup differences
in the HUs of the WM1 between the groups.
The DCW values in the control and GOS 5 groups
were significantly higher than those in the GOS 3&4
(P < 0.01), GOS 2 (P < 0.001), and GOS 1 (P < 0.001) groups
(Figure 3). The DCW value in the GOS 3&4 group was sig-
nificantly higher than that in the GOS 2 group (P < 0.001),
and the DCW value in the GOS 2 group was signifi-
cantly higher than that in the GOS 1 group (P < 0.001).
In addition, the DCW values in the GOS 3,4,5 groups
were significantly higher than those in the GOS 1&2
groups (P < 0.001).
Using ROC analysis, we determined that a DCW cut-
off value of less than 5.5 was predictive of poor neuro-
logical outcome defined as GOS 1&2, with a sensitivity
of 63%, specificity of 100%, positive predictive value of





Measurement by our original method
Cerebral cortex 32.1 (2.9) 36.2 (1.4) <0.001
White matter 1 29.8 (2.3) 30.1 (1.2) 0.69
DCW 2.2 (1.6) 6.1 (1.4) <0.001
Measurement by Torbey et al. method
Gray matter
Caudate nucleus 34.6 (2.5) 36.7 (1.4) 0.006
Putamen 33.4 (2.5) 35.3 (2.4) 0.21
White matter 2
Posterior limb of internal capsule 30.9 (2.6) 32.4 (1.7) 0.04
Corpus callosum 29.5 (2.5) 30.4 (1.7) 0.21
GM/WM2 ratio 1.12 (0.1) 1.13 (0.1) 0.71
Values are mean (SD). HU, Hounsfield unit; GOS, Glasgow Outcome Scale; SD,
standard deviation; DCW, difference in HU values between the cerebral cortex
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Figure 2 Hounsfield units (HU) of the cerebral cortex (left) and white matter 1 (right) of 4 the groups. There were no significant
intergroup differences in the HU values of the white matter 1 among these groups. C, Control. †P < 0.001 vs C and GOS 5 groups, **P < 0.01 vs C
















Figure 3 Differences between the cerebral cortex and white matter 1 (DCW) values among the groups. The DCW values on the Y axis
gradually decreased in accordance with worsening of neurological outcome. Box and whisker plots with median, lower and upper quartiles, and outliers
are shown. C, Control. †P < 0.001 vs C and GOS 5 groups, **P < 0.01 vs C and GOS 5 groups, ††P < 0.001 vs GOS 1 group, *P < 0.001 vs GOS 2 group.
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A neurological predictor of mortality from post-cardiac
arrest syndrome is important from the perspectives of
containing costs and explaining to patients’ families is-
sues concerning neurological outcome. Predictors such
as neurological examinations, electroencephalograms,
and biochemical markers, which are influenced by seda-
tive drugs or hypothermia therapy, are difficult to apply
[5,6]. Most previous studies have collated CT findings
and neurological outcomes after ROSC in patients who
were not treated with hypothermia therapy [4,7-9].
ROSC after prolonged, complete, whole-body ischemia
is an unnatural pathophysiological state that is created
by successful cardiopulmonary resuscitation. Recently,
post-cardiac arrest syndrome has been defined to consist
of a complex combination of pathophysiological pro-
cesses that include hypoxic brain damage, post-cardiac
arrest myocardial dysfunction, and systemic ischemia/
reperfusion response [1,10,11]. Post-cardiac arrest syn-
drome is potentially treatable, although survival and
neurological outcome depend essentially on time factors
following the arrest. Post-cardiac arrest care has signi-
ficant potential to reduce early mortality caused by
hemodynamic instability and later morbidity and morta-
lity from multiple organ failure and brain injury. The
objectives of post-cardiac arrest care are to optimize
ventilation and oxygenation, treat hypotension and acute
coronary syndrome, apply hypothermia therapy, avoid
mechanical lung injury, and reduce multiple organ fai-
lure [1,12].
Hypothermia is a helpful therapeutic approach for the
protection of brain cells in patients who remain coma-
tose after ROSC [13-15]. Two randomized clinical trials
and a meta-analysis have shown improved outcomes in
adults who remained comatose after initial resuscitation
from out-of-hospital ventricular fibrillation cardiac arrest
and who were cooled within minutes to hours after
ROSC [16-18]. The 2010 American Heart Association
Guidelines for Cardiopulmonary Resuscitation and Emer-
gency Cardiovascular Care recommend that comatose
adult patients with ROSC after out-of-hospital ventricular
fibrillation, pulseless electrical activity, or asystole cardiac
arrest should undergo hypothermia cooling for 12 to
24 hours [12].
Our finding that decreasing DCW values were ob-
tained on head CT scans within a very early time from
ROSC was surprising. HU values of the cerebral cortex
gradually decreased in accordance with worsening of
neurological outcome in just a few hours after ROSC.
However, the HU values of the cortical WM1 did not
change relative to neurological outcome. HU changes
depend on the water content in brain tissue, and there is
more water content in the cerebral cortex than in the
WM [19]. If the ischemic insult that occurs to the brainresults in edema, the edema occurs more often in the
cerebral cortex than in the WM.
Several reports have discussed head CT findings in pa-
tients with anoxic brain damage. Torbey et al. showed a
correlation between GM/WM ratios measured at the
level of the basal ganglia and neurological outcomes in
patients after ROSC [4]. A loss of GM/WM differenti-
ation on CT has been reported to predict poor outcome
after hypoxic brain damage and hypoxic encephalopathy.
In addition, Choi et al. reported that the density ratio of
GM to WM on head CT images that were obtained
within 24 hours of ROSC correlates with outcome in co-
matose patients after cardiac arrest [7]. However, the pa-
tients in both of these studies had undergone head CT
within 24 hours of ROSC.
In our observation of the density ratio of GM to WM2
on head CT images early after ROSC by Torbey’s
method, we found no significant difference in the GM/
WM2 ratio between the GOS 1&2 and GOS 3–5 com-
posite groups. We thought the reason for this result was
that HUs of the cerebral cortex were more changeable
than HUs of the posterior limb of the internal capsule or
caudate nucleus in the very early time after ROSC due
to differences in the water content of each tissue and in
how hypoxia exerts its influence in a tissue-dependent
manner.
We determined the measurement of DCW in our
study based on the following reasoning. First, we realized
that in cases of hypoxic-ischemic brain damage follow-
ing cardiac arrest, CT findings show a loss of difference
between GM and WM in the presence of diffuse brain
swelling. We intended to measure the HU differences
between the cerebral cortex and WM1 on the basis of
findings showing a loss of difference between the GM
and WM. Second, we measured GM and WM2 using
the method described by Torbey et al. but found that in
the very early phase after ROSC, the GM/WM2 ratio
did not correlate with neurological prognosis.
Our findings suggested that DCW may be one pre-
dictor of neurological outcome of patients in the early
phase after cardiac arrest. The most important finding of
the present study was that prediction of neurological
outcome could be made within a few hours after ROSC.
With respect to patient background, there were some
differences in each group. In the GOS 5 group, the per-
centage of witnessed arrest patients was 90%, but that in
the GOS 1 and 2 groups was 29% and 61%, respectively.
The time interval between cardiac arrest and ROSC was
longer in patients without good neurological outcomes.
These results suggested that the duration of hypoxia in
the GOS 1 and 2 groups was longer than that of the
GOS 5 group.
The cut-off value for DCW predicting poor neurological
outcome was less than 5.5 in the GOS 1&2 groups, with a
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of the DCW cut-off value as a prognostic indicator in the
present study was comparable to that of the previous
method using the cut-off value for GM/WM ratio of less
than 1.22 [7], which predicted a poor neurological out-
come with lower sensitivity and specificity.
Recently, the medical staff at our hospital has been
able to view X-ray and CT films of electronic charts at
various computer terminals throughout the hospital.
This system allows easier access to measured HU values
and distance and angle measurements of images in the
intensive care unit or in other wards. We are now able
to quickly and easily assess HU values of patients with
post-cardiac arrest syndrome throughout our hospital.
Our study has several limitations. First, this was a retro-
spective, uncontrolled study. However, all brain CT scans
were performed according to a standardized protocol. Sec-
ond, HU values are affected by beam hardening artifacts
of bone or air. Therefore, we very carefully selected the
measurement points on CT images to avoid this. Third,
although the groups seemed similar in all baseline com-
parisons (Table 1), there were differences between the
groups in sex ratio, percentage of witnessed arrests, and
time interval between cardiac arrest and ROSC. Fourth,
the small sample size of the study group could have ob-
scured differences in some of these parameters. Therefore,
a well-designed prospective study of a larger number of
patients is needed to confirm the cut-off value for DCW
that will predict neurological outcome for patients with
post-cardiac arrest syndrome.Conclusions
Our study showed that DCW values obtained from CT
scanning performed within a very short time after ROSC
may be used for the prediction of neurological outcome
of patients with post-cardiac arrest syndrome. Especially,
a cut-off value for DCW of less than 5.5 may be predic-
tive of poor neurological outcome.
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